N. Danziger and S. Alamowitch, Infarctus cérébral, Neurologie ». 7 ème édition actualisée. MED- LINE. Juin 2012, p.261

P. Mismetti and S. Laporte, Rivaroxaban : données pharmaco-cliniques. Annales françaises d'anesthésie et de réanimation, 2008.
DOI : 10.1016/s0750-7658(08)75142-6

P. Mismetti and S. Laporte, Dabigatran : données pharmaco-cliniques. Annales françaises d'anesthésie et de réanimation, pp.8-14, 2009.

X. Delavenne and P. Zufferey, Nouveaux anticoagulants oraux : mécanisme d'action et données pharmacocinétiques, pp.78-82

R. Altman and H. Vidal, Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective. Thrombosis journal, 2009.

. Becker, Rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonist for prevention of stroke and embolism trial in atrial fibrillation: rationale and design of the ROCKET AF study, American Heart journal, vol.159, issue.51, pp.340-347, 2010.

. Patel, Rivaroxaban versus warfarin in non valvular atrial fibrillation. The new England journal of medicine, pp.883-891, 2010.

. Fox, Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment, European Heart Journal, vol.32, issue.19, pp.2387-2394, 2011.
DOI : 10.1093/eurheartj/ehr342

. Connolly, Apixaban in patients with atrial fibrillation. The new England journal of medicine, pp.806-817, 2011.

. Granger, Apixaban versus warfarin in patients with atrial fibrillation. The new England journal of medicine, pp.981-992, 2011.

. Connolly, Dabigatran versus warfarin in patients with atrial fibrillation. The new England journal of medicine, pp.1139-1151, 2009.

. Wallentin, Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial, The Lancet, vol.376, issue.9745, pp.975-983, 2010.
DOI : 10.1016/S0140-6736(10)61194-4

. Diener, Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial, The Lancet Neurology, vol.9, issue.12, pp.1157-1163, 2010.
DOI : 10.1016/S1474-4422(10)70274-X

. Lauer, Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation, pp.1654-1662, 2011.